Bring your portfolio to life with these 3 healthcare shares

The CSL Limited (ASX:CSL) share price is one of three which I think have significant upside potential in the future…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Due to growing and ageing populations, increased chronic burden, and improvements in treatments, demand for healthcare services is expected to grow at a solid rate for the next couple of decades.

In my opinion this makes the healthcare sector a great place for investors to look for long-term buy and hold investments.

Three healthcare shares which I think will outperform the market over the next few years are listed below. Here's why I like them:

CSL Limited (ASX: CSL)

Its shares may be close to an all-time high but I still see a lot of value in this biotherapeutics company for investors with a long-term view. As well as its increasingly profitable immunoglobulins and specialty products, I believe CSL's fledgling vaccines business will be a key driver of growth in the future.

Nanosonics Ltd. (ASX: NAN)

Although this infection control specialist's popular trophon EPR product continues to grow its installed base at a rapid rate, it still only has an estimated 12% share of the total market. Considering the technology is regarded as best in class, environmentally friendly, and wholly effective at disinfecting ultrasound probes, I suspect that it will continue to capture market share over the next few years.

Ramsay Health Care Limited (ASX: RHC)

As a leading private hospital operator I think Ramsay is in a great position to profit from the tailwinds of ageing population's globally and increased cases of chronic disease. Although FY 2018's guidance underwhelmed the market and caused its shares to sink lower, I believe investors should look beyond this and focus on its solid long-term growth prospects.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »